The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program.
佛罗里达儿科 NCORP 续展拨款申请
基本信息
- 批准号:10229382
- 负责人:
- 金额:$ 71.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:African AmericanApplications GrantsCancer BurdenCancer ControlCaringChildChildhoodClinical TrialsCommunitiesCommunity Clinical Oncology ProgramCommunity HospitalsCountryCountyDevelopmentDiagnosisEnrollmentEnsureFamilyFloridaGeneral HospitalsGeographyGoalsGrantHealthHispanicsHomeHospitalsInterventionLatinoMainstreamingMalignant NeoplasmsMinorityOperative Surgical ProceduresPathologyPatientsPatterns of CarePediatric HospitalsPediatric OncologyPediatric Oncology GroupPopulationProceduresProtocol ComplianceProtocols documentationQuality ControlQuality of CareRadiation therapyResearchRisk FactorsScienceSiteTimeTreatment Protocolsbasecancer carecare deliverychemotherapydata qualitymemberpatient populationpopulation basedprogramsresearch based treatmentsuccess
项目摘要
Project Summary
The Florida Pediatric NCORP will be a consortium of five Florida hospitals. The NCORP will
geographically cover a large portion of Florida and will provide pediatric oncology care to the
largest population centers in Florida, the third largest state in the country. The hospitals are
located in Ft. Myers, Hollywood, Orlando, and two sites inTampa, as well as the Central Office.
Over a 34 year period the Florida Pediatric CCOP and now Florida Pediatric NCORP is among
the single largest contributor of patients to COG treatment, cancer control, and over the last two
years, cancer care delivery studies. The CCOP and now the NCORP has consistently had
outstanding compliance scores and contributes to the administration and science of COG
through its members who chair or co-chair research base protocols. The goal of the Florida
Pediatric NCORP will be a continuing effort to make available the latest advances in cancer
care to patients in Florida through participation in clinical trials and to register the majority of
their eligible patients on COG protocols, thereby providing quality care in patients’ home
communities. The Florida Pediatric NCORP will provide a unique opportunity to study a
geographically-defined population to investigate risk factors, patterns of care, and population-
based interventions. The Florida Pediatric NCORP will also maintain a Patient Log which affords
the opportunity to ensure the majority of eligible patients are registered on appropriate COG
protocols. Over the last grant cycle, the five Florida Pediatric NCORP participating sites have
averaged 270 patient registration on COG treament, cancer control, and cancer care delivery
protocols, as well as 321 biospeciem. The Florida Pediatric NCORP anticipates increased
patient registrations as more COG treatment, cancer control, and cancer care delivery protocols
become available. COG quality-control procedures will apply uniformly to the Florida Pediatric
NCORP, ensuring compliance with protocols and external review of pathology, radiotherapy,
surgery, and chemotherapy.
项目摘要
佛罗里达州儿科NCORP将由五家佛罗里达州医院组成联盟。NCORP将
覆盖佛罗里达州的大部分地区,并将为
美国第三大州佛罗里达州是最大的人口中心。医院是
位于堡垒。迈尔斯,好莱坞,奥兰多,以及坦帕的两个地点,以及中央办公室。
在34年的时间里,佛罗里达州儿科CCOP和现在的佛罗里达州儿科NCORP是
患者对COG治疗、癌症控制和过去两年的最大贡献
多年来,癌症护理服务的研究。CCOP和现在的NCORP一直有
出色的合规性得分并为COG的管理和科学做出贡献
通过其担任研究基础方案主席或联合主席的成员。佛罗里达州的目标是
儿科NCORP将继续努力提供癌症的最新进展
通过参与临床试验为佛罗里达州的患者提供护理,并登记大多数
他们符合COG协议的患者,从而在患者家中提供高质量的护理
社区。佛罗里达州儿科NCORP将提供一个独特的机会来研究
地理定义的人口,调查风险因素、护理模式和人口-
以干预为基础。佛罗里达州儿科NCORP还将维护一份患者日志,该日志提供
确保大多数符合条件的患者在适当的COG上注册的机会
协议。在上一个赠款周期中,佛罗里达州五个参与NCORP儿科项目的地点
平均有270名患者登记参加COG治疗、癌症控制和癌症护理服务
协议,以及321生物种。佛罗里达州儿科NCORP预计将增加
患者登记为更多COG治疗、癌症控制和癌症护理提供方案
变得有空。COG质量控制程序将统一适用于佛罗里达州儿科
NCORP,确保遵守方案和病理、放射治疗、
手术和化疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY P KRISCHER其他文献
JEFFREY P KRISCHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY P KRISCHER', 18)}}的其他基金
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
有限的竞争:在年轻研究中糖尿病的环境决定因素(TEDDY)中继续对受试者进行随访并启动第二个病例对照队列
- 批准号:
10398923 - 财政年份:2021
- 资助金额:
$ 71.37万 - 项目类别:
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
人类基因转移
- 批准号:
10403442 - 财政年份:2021
- 资助金额:
$ 71.37万 - 项目类别:
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
人类基因转移
- 批准号:
10179934 - 财政年份:2021
- 资助金额:
$ 71.37万 - 项目类别:
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
有限的竞争:在年轻研究中糖尿病的环境决定因素(TEDDY)中继续对受试者进行随访并启动第二个病例对照队列
- 批准号:
10227415 - 财政年份:2021
- 资助金额:
$ 71.37万 - 项目类别:
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
人类基因转移
- 批准号:
10702185 - 财政年份:2021
- 资助金额:
$ 71.37万 - 项目类别:
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
青年糖尿病环境决定因素研究(TEDDY)中的受试者跟踪、综合数据分析和病毒抗体测量
- 批准号:
10392400 - 财政年份:2020
- 资助金额:
$ 71.37万 - 项目类别:
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
青年糖尿病环境决定因素研究(TEDDY)中的受试者跟踪、综合数据分析和病毒抗体测量
- 批准号:
10260891 - 财政年份:2020
- 资助金额:
$ 71.37万 - 项目类别:
NIDDK Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)
NIDDK 青年糖尿病环境决定因素研究 (TEDDY) (UC4) 中受试者和免疫学评估的后续行动
- 批准号:
10088137 - 财政年份:2017
- 资助金额:
$ 71.37万 - 项目类别:
Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)USF: TrialNet UC4-3
1 型糖尿病数据协调中心 TrialNet (UC4)USF:TrialNet UC4-3
- 批准号:
9506924 - 财政年份:2017
- 资助金额:
$ 71.37万 - 项目类别:
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED) - DCC
多中心介入性淋巴管平滑肌瘤病早期疾病试验 (MILED) - DCC
- 批准号:
10249943 - 财政年份:2016
- 资助金额:
$ 71.37万 - 项目类别: